Process for the preparation of 17-phenyl-18,19,20-thinor-pgf 2a and its derivatives
The present invention provides a new and effective process for the synthesis of 17-phenyl-18,19,20-trinor-PGF 2α and its derivatives, including the anti-glaucoma drugs Bimatoprost and Latanoprost. The benefit of the present invention rises inter alia from the fact that a major intermediate involved in the synthesis of the above compounds may be isolated from a mixture containing also an undesired isomer, by crystallization. In addition, the undesired isomer may be oxidized to give the starting compound, which is then recycled.
1. A process for the preparation of compound of Formula (1b)
wherein R 6 is selected from the group consisting of alkoxy and alkylamino; such process comprising:
(a) stereoselective reduction of the carbonyl group of the compound (4)
to yield a mixture of compounds of formulae (5a) and (6a),
where (5a) is the predominant isomer, which are subsequently converted into a mixture of compounds of formulae (5) and (6):
where one of R 1 and R 2 is an arylcarbonyl group and the other one is selected from the group consisting of arylcarbonyl, acyl, trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted and alkyl-substituted tetrahydro-2H-pyran-2-yl and tetrahydrofuran-2-yl; followed by isolation of the compound (5) from the mixture;
(b) converting compound (6) from the mother liquor of step (a) into compound (6a), oxidizing the hydroxyl group of the compound (6a) to yield the compound (4) and recycling the compound (4) to step (a);
(c) reducing the compound (5) with diisobutylaluminum hydride while maintaining the reaction mixture temperature in the range of from −20° C. to +20° C. followed by hydrolysis of the obtained reaction mixture under basic conditions to give the compound (11),
wherein R 3 is hydrogen when R 1 is acyl and is equal to R 1 when it is trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted or alkyl-substituted tetrahydro-2H-pyran-2-yl or tetrahydrofuran-2-yl; R 4 is hydrogen when R 2 is acyl and is equal to R 2 when it is trialkylsilyl, dialkylarylsilyl, 1-alkoxyalkyl, unsubstituted or alkyl-substituted tetrahydro-2H-pyran-2-yl or tetrahydrofuran-2-yl;
(d) reacting compound (11) with a metal salt of 5-(triphenylphosphoranylidene)pentanoic acid, to obtain the compound of formula (1a)
and
(e) alkylation or amidation of the carboxyl group of compound (1a), optionally, after deprotecting the hydroxyl groups, to give the desired compound (1b).
2. A process according to claim 1 wherein one of R 1 and R 2 is arylcarbonyl and the second one is selected from the group consisting of unsubstituted and alkyl-substituted tetrahydro-2H-pyran-2-yl and tetrahydrofuran-2-yl groups and arylcarbonyl group.
3. A process according to claim 1 wherein one of R 1 and R 2 is arylcarbonyl and the second one is selected from the group consisting of benzoyl, p-toluoyl, p-phenylbenzoyl (PPB) and tetrahydro-2H-pyran-2-yl (THP) groups and R 6 is a hydroxy, methoxy, isopropoxy or ethylamino group.
4. A process according to claim 1 wherein R 1 is p-phenylbenzoyl group and R 2 is tetrahydro-2H-pyran-2-yl (THP) group.
5. A process according to claim 1 wherein said stereoselective reduction of the carbonyl group of the compound (4) in step (a) is carried out by (−)-B-chlorodiisopinocampheylborane.
6. A process according to claim 1 , which further comprises purifying the compound of formula (5) obtained in step (a) by re-crystallization.
7. A process for the preparation of compound of the formula [5] (5a)
which comprises reducing a compound of the formula (4)
wherein R 1 is an aryl carbonyl group, with (−)-B-chlorodiisopinocampheylborane.
8. The process according to claim 7 , wherein said process is maintained at a reaction mixture temperature in the range of from −50° C. to 20° C.
9. The process according to claim 7 , further comprising the step of quenching said reduction with a boron complexing agent.
10. The process according to claim 8 , wherein said boron complexing agent is methanol.
11. A process for the preparation of compound of the formula (5a):
which comprises the steps of:
(a) reducing a compound of the formula (4):
wherein R 1 is an aryl carbonyl group, with (−)-B-chlorodiisopinocampheylborane; and
(b) quenching said reduction step.
12. The process according to claim 11 , wherein said reduction is maintained at a reaction mixture temperature in the range of from about −50° C. to 20° C.
13. A process for the preparation of compound of the formula (5a):
which comprises the steps of:
(a) reducing a compound of the formula (4)
wherein R 1 is an aryl carbonyl group, with (−)-B-chlorodiisopinocampheylborane; while
maintaining a reaction mixture temperature in the range of from −50°C. to 20° C.; and
(b) quenching said reduction step with a boron complexing agent.
14. The process according to claim 13 , wherein said boron complexing agent is methanol.